An international leader in advanced medical technology solutions, KDA powers healthcare innovation in a humane, safe and secure manner.
KDA develops digital and artificial intelligence solutions, specialized medical education and training, consulting, and replacement of professional resources in the health sector.
KDA takes on global health challenges on every continent.
January 2025. It is with great excitement and pride that we share with you a photo of the outdoor display at the Market Center in downtown Toronto to celebrate the 10-year anniversary of KDA Group Inc.’s listing on TSXV. See picture
March 2024. The KDA Group is pleased to announce an update in the development and use of its Adherize+ platform. With the aim of assisting and improving the follow-up of hormone-dependent breast cancer patients taking oral CDK 4/6 inhibitor therapy, the Corporation, through its Adherize+ platform, will develop the monitoring and follow-up algorithm for these patients in collaboration with oncology physicians and pharmacists.
March 2024. The KDA Group is proud to announce that it is working with several Quebec and Canadian pharmacy banners to ensure the performance of its pharmacological adherence software, Adherize+.
Join an experienced international team pioneering the development of ground-breaking solutions that are transforming global healthcare systems.